Filed: 5/15/2023ACC: 0000950123-23-004993
📋 What this filing means
ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $6.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$6.34M
Total AUM (reported)
16.13M
Total Shares
Allocation by class
COM$4.98M78.5%
CLASS A COM$1.36M21.5%
Portfolio Concentration
Top 3$6.34M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.13M
Sole
Full voting authority
9.11M
shares
% of voting shares56.5%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
7.02M
shares
% of voting shares43.5%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 56.5% of voting shares
Institutional Holdings3
Rows:
MEDAVAIL HOLDINGS INC
SOLEShares15.03M
TypeSH
Market value$4.31M
67.93%
Sole
8.01M
Shared
0.00
None
7.02M
RAPID MICRO BIOSYSTEMS INC
SOLEShares1.04M
TypeSH
Market value$1.36M
21.45%
Sole
1.04M
Shared
0.00
None
0.00
PULMONX CORP
SOLEShares60.20K
TypeSH
Market value$673.1K
10.62%
Sole
60.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MEDAVAIL HOLDINGS INCSOLE | COM | 15.03M | SH | $4.31M 67.93% | 8.01M | 0.00 | 7.02M |
RAPID MICRO BIOSYSTEMS INCSOLE | CLASS A COM | 1.04M | SH | $1.36M 21.45% | 1.04M | 0.00 | 0.00 |
PULMONX CORPSOLE | COM | 60.20K | SH | $673.1K 10.62% | 60.20K | 0.00 | 0.00 |